The bottom line Oral semaglutide (Wegovy) is now FDA-approved for weight loss
Complete denervation of the gastrocnemius muscle increases ROS formation, leading to increased lipid peroxidation, further protein degradation, and muscle atrophy
As usual, the devil is not in the bottle
Zheng, H3K18 lactylation potentiates immune escape of non-small cell lung cancer
Sources such as dairy products, eggs, fish, meat, and fortified cereals are a great way to ensure daily intake of B12
The Orange Book does not contain: Manufacturing process patents, even when those patents represent a meaningful barrier to generic manufacturing Patents held by third parties that are not assigned to the NDA holder, such as platform delivery technology patents held by a contract manufacturer Any patent related to the active pharmaceutical ingredient that was not submitted by the brand for listing International patents that may inform domestic prosecution and claim construction arguments Continuation and divisional applications still in prosecution at the USPTO, which can issue as new listed patents at any point Unpublished patent applications within the 18-month publication window ANDA filing history, including whether any generic has filed against a listed product, who filed first, and what type of certification accompanied the filing Paragraph IV notification letters or litigation case numbers Settlement agreement terms or agreed-upon entry dates Post-approval supplemental NDA activity that has not yet been translated into a new Orange Book patent listing Biologics
.png)
